Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for OCGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.74 9.64 %
R2 1.69 6.28 %
R1 1.66 4.20 %
Current price: 1.59
Support S1 1.55 -2.52 %
S2 1.52 -4.60 %
S3 1.46 -7.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.83 15.09 %
R2 1.73 8.81 %
R1 1.64 3.14 %
Current price 1.59
Support S1 1.34 -15.72%
S2 1.32 -16.98%
S3 1.24 -22.01%

OCGN Predictions History

2 years ago
Cassandra Burke predicted that OCGN for 2022-04-07 is going $3.10 (1.64%)

Rank:

2 years ago
Schuman predicted that OCGN for 2022-03-01 is going

Rank:

2 years ago
JS predicted that OCGN for 2022-02-10 is going $4.12 (6.46%)

2 years ago
borrellijr predicted that OCGN for 2022-02-10 is going $12.00 (201.51%)

Rank:

2 years ago
Schuman predicted that OCGN for 2022-01-18 is going $4.00 (0.00%)

Rank:

2 years ago
JS predicted that OCGN for 2022-01-11 is going $4.56 (9.62%)

2 years ago
JS predicted that OCGN for 2022-01-10 is going $3.97 (-8.10%)

2 years ago
irawesome99.234992 predicted that OCGN for 2022-01-10 is going

Rank:

2 years ago
JS predicted that OCGN for 2021-11-05 is going $11.09 (8.30%)

2 years ago
aminmike predicted that OCGN for 2021-11-05 is going

Rank:
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT